INMB vs GILD: Which Stock is Better?
Side-by-side comparison of Inmune Bio Inc and Gilead Sciences Inc in 2026
INMB
Inmune Bio Inc
$1.29
GILD
Gilead Sciences Inc
$138.67
Key Metrics Comparison
| Metric | INMB | GILD | Winner |
|---|---|---|---|
| Market Cap | $33.50M | $174.33B | GILD |
| P/E Ratio | N/A | 20.72 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 2.6% | 0.0% | INMB |
| Gross Margin | 100.0% | 78.8% | INMB |
Analyze INMB
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INMB or GILD a better investment?
Comparing INMB and GILD: Inmune Bio Inc has a market cap of $33.50M while Gilead Sciences Inc has $174.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INMB and GILD?
INMB (Inmune Bio Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INMB or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INMB or GILD?
INMB has higher revenue growth at 2.6% vs 0.0% for GILD.
Which company is more profitable: INMB or GILD?
Inmune Bio Inc (INMB) has higher gross margins at 100.0% compared to 78.8% for GILD.
Which is the larger company: INMB or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $174.33B compared to $33.50M for INMB.
Should I buy INMB or GILD in 2026?
Both INMB and GILD have investment merit. INMB trades at $1.29 while GILD trades at $138.67. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INMB and GILD stock?
Key differences: Market Cap ($33.50M vs $174.33B), P/E Ratio (N/A vs 20.7x), Revenue Growth (2.6% vs 0.0%), Gross Margin (100.0% vs 78.8%).